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The sequence specificity of chicken mRNA A@-aden- 
osine methyltransferase has been investigated in vivo. 
Localization of six new NB-methyladenosine sites on 
Rous sarcoma virus (RSV) virion RNA has confirmed 
our extended consensus sequence for methylation: 
RGACU, where R is usually a G (7/12). We have also 
observed A (2/12) and U (3/12) at the -2 position 
(relative to meA at +l) but never a C. At the +3 posi- 
tion, the U was observed 10112 times; an A and a C 
were observed once each in weakly methylated se- 
quences. The extent of methylation varied between the 
different sites up to a maximum of about 90%. To test 
the significance of this consensus sequence, it was al- 
tered by site-specific mutagenesis, and methylation 
was assayed after transfection of mutated RSV DNA 
into chicken embryo fibroblasts. We found that chang- 
ing the G at -1 or the U at +3 to any other residue 
inhibited methylation. However, inhibition of methyl- 
ation at all four of the major sites in the RSV src gene 
did not detectably alter the steady-state levels of the 
three viral RNA species or viral infectivity. Additional 
mutants that inactivated the src protein kinase activity 
produced less virus and exhibited relatively less src 
mRNA in infected cells. 
N6-Methyladenosine (m6A)’ is the major methylated resi- 
due found at internal sites in mRNAs of higher eukaryotes 
(reviewed in Banerjee (1980)). Pre-mRNAs are methylated in 
the nucleus prior to polyadenylation (Perry et al., 1975), and 
the bulk of the methylated bases appears to be conserved 
during processing to mature cytoplasmic mRNA (Chen-Kiang 
et al., 1979). Studies in a number of different cell types have 
demonstrated that internal m6A methylation occurs exclu- 
sively at the sequences GAC or AAC, with GAC being more 
frequently used (Canaani et al., 1979; Dimock and Stoltzfus, 
1977; Schibler et al., 1977; Wei and Moss, 1977). GAC and 
AAC should appear every 32 nucleotides in a random se- 
quence; however, only one m6A residue is seen per approxi- 
mately 1000 nucleotides in total mammalian cell mRNA 
(Adams and Cory, 1975; Desrosiers et al., 1975; Lavi et al., 
1977; Perry et al., 1975; Wei et al., 1976). This suggests either 
that methylation occurs inefficiently at many sites or that 
there is additional enzyme specificity for methylation, perhaps 
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at the level of RNA secondary structure or of more extensive 
sequence specificity. Some effort has been made to identify 
conserved nucleotides flanking the RAC consensus sequence. 
At the -2 position (2 bases upstream of the m6A at +l), a 
purine was observed 90% of the time in mouse mRNA and 
hnRNA, and A, U, or C was observed at the +3 position 
(Schibler et al., 1977). Similarly, in HeLa cell mRNA, the 
base following m6AC is never G (Wei and Moss, 1977). 
RGACU was observed to be a preferred methylation sequence 
in Rous sarcoma virus (RSV) RNA on the basis of comparison 
of seven m6A sites; however, one of these sites had a U at -2 
(Kane and Beemon, 1985). 
If m6A residues were distributed uniformly between 
mRNAs, an average mammalian cell mRNA would have ap- 
proximately three m6A residues (Adams and Gory, 1975; Des- 
rosiers et al., 1975; Lavi et al., 1977; Perry et al., 1975; Wei et 
al., 1976). The distribution of m6A residues in specific mRNAs 
has been studied in only a few cases; however, it is definitely 
nonrandom. Both the number and positions of m6A residues 
vary with different mRNAs. Most of the m6A in adenovirus 
is found within the 5’ two-thirds of the viral mRNAs (Sommer 
et al., 1976), and simian virus 40 late mRNAs are methylated 
near their 5’-ends (Canaani et al., 1979). In contrast, bovine 
prolactin mRNA is methylated at a single site which is within 
its 3’-noncoding region (Horowitz et al., 1984; Narayan and 
Rottman, 1988). RSV has from 12 to 15 m6A residues per 
genomic RNA subunit, on average (Beemon and Keith, 1977; 
Furuichi et al., 1975; Stoltzfus and Dimock, 1976), predomi- 
nantly in the 3’-half of the virion RNA (Beemon and Keith, 
1977; Kane and Beemon, 1985). Precise localization on the 
RSV genome has identified 3 m6A residues in src and 4 in env 
coding sequences (Kane and Beemon, 1985). The extent of 
methylation varies between different sites in RSV RNA, with 
some being nearly stoichiometric while others are only rarely 
used (Dimock and Stoltzfus, 1977; Kane and Beemon, 1985). 
There are numerous RGACU sequences in the 5’-half and 
some in the 3’-half of RSV RNA which are not detectably 
methylated (Beemon and Keith, 1977; Kane and Beemon, 
1985). 
In this paper, we have extended our previous localization 
of methylated bases in RSV virion RNA at the nucleotide 
level and have identified six additional mfiA sites in the src 
coding region of RSV. Comparison of sequences containing 
these sites has confirmed our extended consensus sequence 
for methylation: RGACU. Site-specific mutagenesis of the G 
at -1 or of the U at +3 in this consensus sequence inhibited 
methylation, as did mutation of the invariant C at +2 in an 
earlier study (Kane and Beemon, 1987). However, mutation 
of the four major m6A sites in the src gene of RSV did not 
have an appreciable effect on steady-state levels of viral RNA 
nor on viral infectivity. 
EXPERIMENTAL PROCEDURES 
Materials-CEF primary cultures were prepared from gs- chf eggs 
supplied by SPAFAS, Inc., Norwich, CT. A full-length clone of PR- 
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C RSV DNA in pBR322 (pATV8K) (Cobrinik et al., 1987) was a gift 
from R. Katz and A. Skalka, Fox Chase Cancer Center. Synthetic 
oligonucleotides were either obtained from Operon, Alameda, CA, or 
were synthesized on an Applied Biosystems model 380A svnthesizer. 
5’-monophosphates were resolved by two-dimensional thin-layer 
chromatography as described (Horowitz et al., 1984). The presence of 
pm’A was detected by comigration with a cold marker nucleotide. 
RNase Protection Assays-The levels of src and enu mRNAs and 
unspliced RNAs were detected by RNase protection assays. Total 
cellular RNA was prepared after cell lysis in RNAzol as described 
(Chomczynski and Sacchi, 1987). RNA species were detected by 
RNase protection assays (Melton et al., 1984). The ribonrobe template 
for assay of enu mRNA was constructed by insertion of a B&HI 
(nucleotide 4716) to XhoI (nucleotide 5258) fragment of PR-C RSV 
into pGEM-2. After template digestion with Dd;I (nucleotide 5045), 
the antisense riboprobe was transcribed with T7 RNA polymerase. 
50 &i of [a-“‘P]CTP were used in this reaction at a final CTP 
concentration of 15 PM. Hybridization with this probe yielded a 213- 
nucleotide unspliced RNA and a 180.nucleotide spliced enu mRNA. 
Splicing at the src splice acceptor site was assaved with a riboprobe 
made from a template spanning RSV sites Xhoi (nucleotide 6983) to 
Z’thlll-I (nucleotide 7330). Hvbridization of this nrobe to RNAs 
from infected cells yielded a 347-nucleotide RNA’which included 
unspliced RNA and enu mRNA, and a 276-nucleotide src-specific 
mRNA. Hybridization was carried out for approximately 18 h at 
55 “C. RNase digestion was in 10 pg/ml RNase A and 10 units/ml 
RNase T, at 23 “C for 1 h. 
[‘“PJOrthophosphate was-obtained from ICN. [r-“‘P]ATP (3000 Ci/ 
mmol) and rc~-‘~PlcTP (400-800 Ci/mmol) were from Amersham 
Corp. RNasei A, ‘?,, T, w&e obtained from Calbiochem; Pl nuclease 
was from Bethesda Research Laboratories; T4 polynucleotide kinase 
was from U. S. Biochemical Corn.: T7 RNA uolvmerase was from 
Pharmacia LKB Biotechnology inc. Marker ;rn’A was from P-L 
Biochemicals. RNAzol was obtained from Cinna/Biotecx. Plasmid 
pGEM-2 was from Promega Biotec. 
Site-spec+c Mutagenesis-Site-specific mutagenesis was carried 
out to alter sequences at m6A sites by the method of Zoller and Smith 
(1984) as previously described (Kane and Beemon, 1987). Mutated 
DNA fragments were sequenced by the method of Sanger et al. (1977), 
as adapted for plasmid DNA (Wallace et al., 1981). The mutated Sac1 
fragment was then inserted into the complete RSV genomic clone, 
pATV8K (Cobrinik et al., 1987). Mutations in the consensus sequence 
flanking the m6A at site 8014 (numbering is according to the sequence 
of Schwartz et al. (1983)) were made in a plasmid bearing previous 
mutations (7415U/7425U) that prevented adenine methylation at 
nucleotides 7414 and 7424 (Kane and Beemon, 1987); thus three 
methylation sites were mutated in all. Mutation 8016G changed the 
U at +3 to a G but did not alter the amino acid sequence of ~~60”“. 
In contrast, mutation 8013U/8016A was a double mutation, which 
altered amino acid 295 of the src protein from Lys to Asn. The 
resulting mutant failed to transform CEFs, as has been observed with 
other mutations which alter this amino acid at the ATP-binding site 
of src (Kamps and Sefton, 1986). Fourth site mutations (at m6A site 
8485) were originally constructed in a plasmid bearing the 8013U/ 
8016A and 7415U/7425U mutations; all of the viruses generated were 
nontransforming. RNA from these viruses was analyzed to determine 
the effects of the mutations on methylation (Table II). However, for 
functional characterization of methylation-deficient viruses, mutants 
8484U and 8487G were reconstructed on an 8016G, 7415U/7425U 
background by replacing the StuI fragment (nucleotide 3316-8042) 
of these viral constructs with the corresponding fragment from 8016G. 
This yielded transforming viruses with four mutations at m6A sites. 
These transforming viruses were used in studies regarding the possi- 
ble functional significance of m”A (Table III, Fig. 2). 
Z’ransfection-Plasmids containing viral DNA were permuted 
around a uniaue KmzI site (Cobrinik et al.. 1987). Before transfection. 
the plasmids were- cut with KpnI and religated to generate concata: 
mers. One c(g of DNA was transfected onto chick embryo fibroblast 
cells with DEAE-dextran, followed by a shock with 10% dimethyl 
sulfoxide as described (Arrigo and Beemon, 1988). 
Preparation and Analysis of Viral RNA-Viral RNA was prepared 
7-14 days after infection of CEFs. Radiolabeling of infected cells with 
“‘P, and isolation of genomic RNA from virus particles were as 
previously described (Kane and Beemon, 1985). For isolation of 35 S 
virion RNA subunits, the 70 S RNA was denatured by boiling for 45 
s and was sedimented through a second lo-25% sucrose gradient. 
The total m6A content of RNA was determined bv digestion with 
RNases A, T,, and T,, followed by two-dimensional electrophoretic 
separation of the mononucleotides as described previously (Beemon 
and Keith. 1977). Fragments of zenomic RNA were isolated bv 
hybridization to nitroceilulose filters to which viral DNA restriction 
fragments had been bound (Kane and Beemon, 1985). RNAs were 
digested with RNase T, and fingerprinted by the method of Barrel1 
(1971) using electrophoresis on DEAE-cellulose paper in the second 
dimension. To localize m6A sites specifically, selected oligonucleotides 
were eluted from the fingerprint and digested to mononucleotides 
with RNases A, T,, and T1. The resulting mononucleotides were 
separated by electrophoresis on Whatman No. 3MM paper in pH 3.5 
buffer (pyridinelacetic acid). The Ap was eluted from the paper and 
separated from m’Ap by thin-layer chromatography on cellulose 
plates as described earlier (Kane and Beemon, 1985). 
This same procedure was used to analyze RNA fragments contain- 
ing mutated m6A sites. Isolation of a 149-nucleotide RNA fragment, 
by hybridization to a MluI-PstI RSV DNA fragment (nucleotide 
7901-8050), allowed analysis of site 8014; and a 246-nucleotide frag- 
ment, obtained by hybridization to a BglI-PstI fragment (nucleotide 
8416-8662), was used to analyze site 8485. To confirm analyses of 
fragments containing mutated m6A sites, unlabeled viral RNA frag- 
ments were digested to 3’.monophosphates with RNases A, T,, and 
Tz and 5’-end-labeled with T4 polynucleotide kinase and 1 &i of [y- 
,l’P]ATP. After removal of the 3’-phosphate with Pl nuclease, the 
Reverse Transcriptuse Assays-The clarified cell culture media was 
assayed for viral reverse transcriptase activity as a measure of virus 
production as described (Kane and Beemon, 1987). 
RESULTS 
Sequence Specificity of Methylation in RSV RNA and 
Chicken mRNA-The average m6Ap content of Prague C RSV 
35 S virion RNA was determined by nucleotide analysis to be 
0.14%, using in uiuo 32P-labeled RNA (data not shown). This 
suggested an average of 12.6 m6Ap residues/9.5-kilobase RNA, 
in good agreement with the level previously observed for 
Prague B RSV RNA (Beemon and Keith, 1977). Individual 
RNase T, oligonucleotides from a homochromatography fin- 
gerprint of total 35 S RSV RNA were also analyzed for their 
m’Ap content. This study detected 18 different methylated 
oligonucleotides, which varied extensively in their extent of 
methylation. Since most of these oligonucleotides are not 
unique in the viral genome, more than 18 potential m6A sites 
are possible. As methylation was previously observed to be 
incomplete at most sites (Kane and Beemon, 1985), it was 
expected that more than 12 methylated sites would be found 
in RSV RNA to generate an average of 12.6 m6A residues. 
The oligonucleotide containing the highest fraction of m’Ap 
(relative to Ap) in RSV 35 S RNA was (G)ACUG (data not 
shown). This sequence contained 4-5 times as much m’Ap as 
the next highest set of methylated sequences: (G)ACUUUN 
and (G)ACUUG. A lower level of m6Ap content was observed 
in a variety of oligonucleotides beginning (G)ACUC/A. A 
barely detectable level of m6Ap was observed in several oli- 
gonucleotides beginning (G)ACA/C. Finally, no m6A was ob- 
served in (G)ACG, (G)ACCG, or (G)ACCCG. The differences 
observed in the average extent of methylation of these differ- 
ent oligonucleotides may reflect different affinities of the 
methyltransferase for the sequences contained in the oligo- 
nucleotide. Alternatively, a single oligonucleotide may be de- 
rived from a mixture of extended sequences, each having 
different affinities for the methyltransferase. 
A similar m’Ap analysis was carried out on total polyade- 
nylated RNA from chicken embryo fibroblasts. We were sur- 
prised to find that the overall level of m6Ap in total cellular 
polyadenylated RNA was 0.055%, which is amost 3 times 
lower than that of the virion RNA. Analysis of intracellular 
viral RNAs also showed a lower level of m’Ap than did the 
corresponding regions in virion RNA.2 As in virion RNA, the 
cellular mRNA oligonucleotide found to contain the most 
’ T. Csepany, unpublished results. 
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m6Ap was (G)ACUG, followed by (G)ACUUUN. Lower 
methylation was detected in (G)ACUUG, (G)ACUAAG, 
and (G)ACCUG, and no detectable m’Ap was ob- 
served in (G)ACG, (G)ACCG, (G)ACCCG, (G)ACCCAG, or 
(G)ACACCG (data not shown). We did not detect m6A in 
AAC sequences unambiguously by this method; however, 
there were several potential AAC substrates (in oligonucleo- 
tides that also contained GAC), which were methylated at a 
low level. In conclusion, the sequence specificity of the meth- 
yltransferase appeared to be similar for viral and cellular 
mRNAs, but the extent of methylation was significantly 
higher for RSV virion RNA than for cellular mRNA. 
Precise Localization of m6A Sites in RSV RNA--To study 
the sequence specificity of the m6A methyltransferase within 
a larger context than a Tl oligonucleotide, we have extended 
our previous studies on localization of m6A in RSV RNA 
(Kane and Beemon, 1985). The region of RSV RNA from 
nucleotide 4715 to 9312 (the 3’ terminus) has been found to 
contain the bulk of the methylated bases, and a detailed 
analysis of RSV RNA regions between nucleotide 4715-5258 
and nucleotide 618558050 was carried out previously (Beemon 
and Keith, 1977; Kane and Beemon, 1985). In the present 
study we analyzed RSV RNA regions between nucleotides 
5564 and 6185 and between 8051 and 8662. The region from 
nucleotide 5564 to 6185 is within the env coding region and 
contains several potential m6A sites (GAC or AAC), including 
one at nucleotide 5849 that fits our extended consensus se- 
quence RGACU. However, analysis of these potential sites 
failed to identify any methylated sites in this region. 
In contrast, we identified five new m6A sites in the src gene 
region of the genomic RNA between nucleotide 8051 and 8662 
(Table I). In addition to the four sites localized precisely, 
methylation was observed at nucleotide 8366 and/or 8369 in 
the sequence AGGACAACG. We have not determined if one 
of the A residues shown in bold type is the preferred methyl- 
ation site or if both the GAC and the AAC sites in this 
oligonucleotide can serve as substrates for the methyltrans- 
ferase. In addition, we were able to resolve the ambiguity at 
m6A site 7890/7981 (Kane and Beemon, 1985) by analyzing a 
smaller RNA fragment. A low level of methylation was de- 
ntb 
6394 GAGACUAGc,d Low 
6447 GGGACUUAUUGd Low 
6507 UUGACUUCUUGd Low 
6718 AGGACUGd 
7414 UGGACUGd 
7424 CGGACUUGd 
7890 GGGACUCG 
8014 AAGACUCUGd 
8339 CUGACUUCG 
8366 AGGACAACG’ 
8413 UGGACAG 
8485 CUGACUG 
8633 AGGACCCUG 
Consensus seauence RGACU 
High 
High 
High 
Low 
High 
Low 
Low 
Low 
High 
Low 
n High methylation denotes 50-90% methylation at a specific site; 
low methylation means approximately 20-30% of all RSV genomic 
RNAs are methylated at this nucleotide. 
b Nucleotides. 
’ The methylated nucleotide is shown in bold type. 
dThese sites were previously identified in Kane and Beemon 
(1985). 
‘We have not determined which A is methylated in this oligonu- 
cleotide. 
tected in the RNA fragment extending from nucleotide 8662 
to 9180, but methylation sites were not definitively identified 
within it. The fragment containing nucleotides 9181-9312 
and nucleotides l-255 had no detectable m6A residues. We 
observed extensive variation in the extent of methylation 
between these different sites, as summarized in Table I. 
By comparing the 12 different methylated sequences pre- 
cisely localized in RSV RNA (Table I), we noticed that the 
GAC sequence was invariant. Further, a U was present at 
position +3 in 10 out of 12 sites. The exceptions at nucleotide 
8413 and 8633 had an A or a C at +3, respectively, and both 
of these sites were weakly methylated. At position -2, we 
observed a G 7 times, an A 2 times, and a U 3 times. We have 
never observed a C at position -2. At positions -3 and +4, 
the sequence appeared to be random. In conclusion, there 
seems to be a strong preferred sequence of methylation: 
RGACU, although the R at -2 can be replaced by a U. 
Analysis of the most highly methylated RSV sequences shows 
three GACUG sequences and one each of GACUUG and 
GACUCUG. This is consistent with the analysis of total viral 
RNA described above, which found that GACUG was the 
most highly methylated sequence, followed by GACUUUN 
and GACUUG. 
Mutagenesis of the m6A Consensus Sequence-To assess the 
significance of various nucleotides within the consensus se- 
quence to recognition by an m6A methyltransferase, we per- 
formed site-specific mutagenesis on the RSV genome. We 
hoped these mutations would also help to address the func- 
tional significance of m6A methylation, so we chose to mutate 
various parts of the consensus methylation sequences of the 
four strong m6A sites localized in the src gene: nucleotides 
7414, 7424, 8014, and 8485. A double viral mutant had been 
constructed previously in which m6A sites 7414 and 7424 were 
simultaneously made methylation-minus by mutating the two 
Cs at the +2 positions to U (7415U/7425U) (Kane and Bee- 
mon, 1987). This mutant was additionally mutated at m6A 
site 8014 to construct mutants 8016G (+3 U to G) and 8013U/ 
8016A. These three-site mutants were additionally mutated 
at site 8485 to generate a series of six different four-site 
mutants. The G at -1 (nucleotide 8484) was changed to A, U, 
or C; alternatively, the U at +3 (nucleotide 8487) was changed 
to A, G, or C. All of these mutations are described in Table 
II. 
Mutated viral DNAs were used to transfect CEFs, and 
virion RNA was harvested. We initially determined the pres- 
ence or absence of m6A in short RNA fragments known to 
contain a single m6A site or a mutated version of this site by 
analyzing in vivo labeled RNA (Kane and Beemon, 1985). 
The major drawback of the in vivo labeling method was the 
difficulty in obtaining sufficient radiolabeled RNA to carry 
out the multiple steps required for m6A analysis. This was 
particularly true for the nontransforming mutant viruses, 
which were expressed at a lower level than the wild type. 
Therefore, these mutants were also analyzed by an in vitro 
labeling method (Horowitz et al., 1984). A representative two- 
dimensional separation of in vitro labeled RNA fragments is 
shown in Fig. 1. The wild-type 246-nucleotide RNA fragment, 
which contains a single m6A site at nucleotide 8485 (panel A) 
was compared with the corresponding fragment derived from 
mutant 8484A in which GAC has been converted to AAC 
(panel B). The mutant clearly has a greatly reduced level of 
m6A in this fragment. 
Mutating the bases at positions -1 (G to A, C or U), +2 (C 
to U), or +3 (U to A, C or G) all resulted in substantial 
inhibition of methylation, so that no m6A was detected at the 
mutated site (Table II). We have not analyzed effects of other 
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TABLE II 
Mutations at m6A sites in RSV RNA 
Mutations at the 8014 site were made in constructs previously 
mutated at both nucleotides 7414 and 7424. Similarly, the 8485 site 
mutations were made in constructs previously mutated at nucleotides 
7414,7424, and 8014. 
Mutation 
m”A 
site sequence 
Mutation 
position Methylation 
None 7414 GGACU None + 
7415U” GGAUUb +2 C-U - 
None 7424 GGACU None + 
7425U” GGAUU” +2 C-&J - 
None 8014 AGACU None + 
8016G AGACG +3 U+G - 
8013U/8016A AUACA -1 G-U/+3 U--tA - 
None 8485 UGACU None + 
8484A UAACU -1 G-+A - 
8484U UUACU -1 G+U - 
8484C UCACU -1 G+C - 
8487G UGACG +3 U+G - 
8487A UGACA +3 U-A - 
8487C UGACC +3 u-4 - 
’ This mutant was described in Kane and Beemon (1987). 
h Mutated nucleotides are shown in bold type. 
FIG. 1. Analysis of m6Ap at site 8485 in wild-type RSV and 
mutant 8484A. The presence of m’Ap in a 246-nucleotide fragment 
containing a single m”A site at nucleotide 8485 was investigated by 
the in vitro labeling method described under “Experimental Proce- 
dures.” This involved two-dimensional thin-layer chromatography. 
The first dimension is from bottom to top, and the second is from 
left to right. A, wild-type virus; B, mutant 8484A. 
mutations at these sites nor of mutations at positions +1 (the 
methylated A is presumed to be invariant) or at -2. It was 
surprising that all of the mutations at site +3 were inhibitory, 
since GACAG sequences (as found in mutant 8487A) have 
been observed to be methylated in total viral and cellular 
RNA, albeit weakly. In contrast, GACG (as in mutant 8487G) 
has never been observed to be methylated in any system. We 
have not observed methylation of GACCG sequences (as in 
mutant 8487C), although other GACC sequences are methyl- 
ated. These particular mutations were made at site 8485 (wild- 
type sequence, UGACUG), which has a nonpreferred U nu- 
cleotide at position -2 and a G at +4. It is possible that the 
+3 mutations would have had a less inhibitory effect if com- 
bined with a G at position -2 or with a different residue at 
+4. We were also surprised that conversion of GAC to AAC 
(mutant 8484A) inhibited methylation (Fig. 1) since AAC is 
observed to be methylated in total cell RNA, although less 
frequently than GAC (Canaani et al., 1979; Dimock and 
Stoltzfus, 1977; Schibler et al., 1977; Wei and Moss, 1977). 
Perhaps this mutation would have had less effect in a different 
context than that at 8485. Alternatively, the sequence context 
required for methylation at AAC sites may be quite different 
than that for GAC sites. 
Functional Analyses of Methyl&ion Mutants-We have be- 
gun to assess the effect of these methylation-minus mutations 
on RSV RNA metabolism. Our earliest mutagenesis studies 
involved mutations at two sites: 7414 and 7424. This double 
mutation did not have any observable effect on RSV infectiv- 
ity, focus formation, intracellular RNA levels, or their sub- 
cellular location (Kane and Beemon, 1987). From this original 
double mutation, additional mutations have been added at 
m”A sites 8014 and 8485, generating viruses with three and 
four mutations in the src gene. These mutations were on a 
background which preserved transforming activity of the virus 
(8016G). Steady-state levels of unspliced, env, and src mRNAs 
in CEFs transfected with the viral mutants were quantified 
by an RNase protection assay, using riboprobes that span the 
env and the src splice acceptor sites. Fig. 2 shows the results 
of an experiment using two of the four-site mutants and one 
of the three-site mutants. The levels of env and src mRNAs 
relative to unspliced RNAs were determined by densitometric 
scanning of the autoradiograms. Cells infected by these trans- 
forming viruses lacking three or even all four of the major 
m6A sites in the src gene generated steady-state levels of viral 
src, env, and unspliced RNAs that were indistinguishable from 
the wild-type levels. 
The infectivity of the various mutant-transforming viruses 
was also studied by means of reverse transcriptase assays. 
Cells infected with equivalent reverse transcriptase units of 
virus from methylation-defective mutants were found to pro- 
duce levels of virus comparable to those of wild-type virus 
(Table III). Thus, no effect of the methylation inhibition was 
observed at the level of viral replication or infectivity. 
In contrast, analysis of virion reverse transcriptase and 
- 
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FIG. 2. RSV RNAs in chicken cells infected with wild-type 
(WI’) or mutant viruses. The levels of unspliced, enu, and src 
mRNAs were determined by an RNase protection assay as described 
under “Experimental Procedures.” Probes spanning the enu and src 
splice acceptor sites were used simultaneously in this assay. M rep- 
resents RNA markers. The four-site mutants 8487G and 8484U also 
contained mutations 8016G and 7415U/7425U. 
TABLE III 
Reverse transcriptase assays 
Duplicate plates of CEFs were infected with equivalent reverse 
transcriptase units of wild-type or mutant virus obtained by transfec- 
tion. After the cells became transformed, 50 11 of culture supernatants 
from each plate were assayed for reverse transcriptase activity in 
duplicate. Reverse transcriptase activity shown in each experiment is 
the average of duplicate transfected plates, normalized with respect 
to wild-type virus. 
Reverse transcriptase activity 
Virus Mean 
Exp. 1 Exp. 2 Exp. 3 
Wild type 100 100 100 100 
8016G 115 130 79 108 
8484U” 117 109 86 104 
8487G” 148 146 108 134 
’ The four-site mutants 84870 and 8484U also contained mutations 
8016G and 7415U/7425U. 
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viral RNA levels revealed severalfold less virus produced by 
the transformation-defective mutant 80l?U/8016A and by all 
of the four-site mutants derived from it (data not shown). 
Interestingly, these mutants all inactivated the src protein 
tyrosine kinase activity by mutating the ATP-binding site 
(amino acid 295) from Lys to Asn. Similar mutations at this 
site have been shown to inactivate the transforming ability of 
the virus (Kamps and Sefton, 1986). When we analyzed the 
steady-state levels of viral RNA in cells transfected with this 
transformation-defective class of mutants, we discovered that 
the src mRNA levels were decreased relative to those of the 
unspliced and em mRNAs (Csepany et al., 1990). Further, 
the src protein levels were decreased relative to the gag protein 
levels in immunoprecipitates from [?S]methionine-labeled 
cells.* These results suggest that cell transformation rather 
than methylation may be facilitating expression of the src 
mRNA, since analogous mutants which inhibited methylation 
but did not affect the src protein sequence had wild-type levels 
of src mRNAs (Fig. 2). 
DISCUSSION 
Localization of 12 m6A residues in the RSV genome has led 
to the derivation of an extended consensus sequence for m6A, 
RGACU. While the central GAC sequence was invariant, we 
have observed some variation from this consensus sequence 
at positions -2 and +3 (U rather than R at position -2 at 
three sites, and one site each with a C and an A at position 
+3). The R at -2 was predominantly G in RSV. The m’A site 
localized in bovine prolactin RNA was at an AGACU se- 
quence (Narayan and Rottman, 1988), which also fits this 
consensus. The expected incidence of RGACU would be every 
512 nucleotides in a random sequence; thus, it is a consider- 
ably better fit than the limited RAC sequence to the actual 
average distribution of m6A observed in mRNAs (about 1 
m6A/1000 nucleotides) (Horowitz et al., 1984; Lavi et al., 1977; 
Perry et al., 1975; Wei et al., 1976). We have also obtained 
evidence of variation in the levels of methylation between 
different sites. In RSV RNA, the RGACU sequence is deli- 
nitely preferred, but not every such sequence is methylated. 
The sites that are methylated in viral RNA vary in extent 
from approximately 20% up to 90%. The m6A sites in RSV 
RNA appear frequently to be tightly clustered together; for 
example, four sites were identified between nucleotides 8339 
and 8485. It also appears that whole regions of an RNA may 
not be available for methylation. There are several RGACU 
sequences in the 5’-half of RSV RNA, but they do not appear 
to be methylated. Thus, the average number of m6A sites in a 
specific RNA appears to reflect both incomplete methylation 
at most sites and an extended consensus sequence. The fact 
that certain regions of an RNA are highly methylated and 
others are not suggests the possibility of favorable secondary 
structures or other factors involved in determining the spec- 
ificity of methylation. 
We have begun to assess the relevance of the RGACU 
consensus sequence for methylase specificity by performing 
oligonucleotide-directed mutagenesis. These studies have re- 
vealed the importance of the G (-l), C (+2), and U (+3) 
residues, since methylation was severely inhibited when any 
one of these bases was mutated. We assume that the methyl- 
ated A is also obligatory but have not mutated it. As expected 
based on the consensus sequence, alteration of the C at +2 or 
changing the G at -1 to a pyrimidine prevented methylation. 
However, it was surprising that the G to A mutation at 
nucleotide 8483, which generated the sequence UAACU, also 
inhibited methylation. Although AAC, as well as GAC, se- 
quences are reportedly methylated in a variety of mRNAs 
(Dimock and Stoltzfus, 1977; Schibler et al., 1977; Wei and 
Moss, 1977), we have not identified any unambiguously meth- 
ylated AAC sites in RSV. It is possible that methylation of 
an AAC requires a different context than that for GAC. It 
has not been established whether a single m6A methylase is 
active at both GAC and AAC sites or whether there are two 
or more independent methylases with different sequence spec- 
ificities. An m6A methylase has not been purified, however, 
methylase activity has been detected in HeLa cell nuclear 
extracts (Narayan and Rottman, 1988). In RSV RNA meth- 
ylated GAC sites appear to be much more abundant than 
AAC sites (Dimock and Stoltzfus, 1977; Kane and Beemon, 
1985; this paper). It is possible that the AAC sites are used 
less efficiently, making them difficult to detect in a specific 
RNA. The finding that virion RNA was more highly methyl- 
ated than chicken cell mRNA or viral mRNA raises the 
possibility that there may also be m6A demethylases in the 
cell. 
Previous studies using methylation inhibitors have sug- 
gested a possible role for m6A in RNA processing or transport 
of mRNA from the nucleus to the cytoplasm (Camper et al., 
1984; Finkel and Groner, 1983; Stoltzfus and Dane, 1982). 
We have generated mutants of RSV that are undermethylated 
at specific sites so as to assess the functional significance of 
the methylation. The RSV src region has four strong m6A 
sites as well as numerous weaker methylation sites. We have 
inhibited methylation at all four of the strong sites but have 
observed no noticeable effect on steady-state levels of viral 
RNA. Viral replication and infectivity, measured by reverse 
transcriptase assays, were also unaffected by undermethyla- 
tion in the src gene. 
Only those methylation-minus mutants which inactivated 
the src kinase activity manifested a phenotype different from 
the wild-type virus. These mutants generated a lower level of 
reverse transcriptase activity than wild type, possibly due to 
a lack of src-mediated activation of transcription from the 
RSV long terminal repeat as has recently been seen in serum- 
starved rat cells (Dutta et al., 1990). In addition, the nontrans- 
forming mutants had a lower relative level of src mRNA and 
protein (Csepany et al., 1990). Both of these phenotypes 
correlated with transformation rather than with methylation. 
The src protein has recently been reported to induce stabili- 
zation of cellular 9E3 mRNA (Stoeckle and Hanafusa, 1989); 
however, enhancement of v-src mRNA levels in RSV-trans- 
formed cells has not been reported previously. The alterations 
in src mRNA levels in the nontransforming mutants could be 
at the level of mRNA splicing, transport, or stability. 
There are several possible explanations for the lack of 
apparent effect of the src methylation mutations on RNA 
metabolism. It is possible that methylation facilitates RNA 
splicing or transport but that the effects are too subtle to be 
seen at the level of steady-state RNA. Alternatively, mfiA sites 
with a function may represent a minority of the total m”A 
sites. It is possible that the multiple m6A sites in RSV are 
somewhat degenerate so that not all need to be methylated 
for function to be maintained. Since the RSV src gene is a 
transduced cellular gene that has lost its introns (Takeya and 
Hanafusa, 1983), it is possible that the m6A sites in src played 
a role in processing of the c-src progenitor but that they are 
not involved in v-src mRNA metabolism. In conclusion, in 
this study we were able to learn more about the sequence 
specificity of the m6A methylase; however, the function of 
this modification in mRNA remains elusive. 
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